Correlative Analytics and Integrated Clinical Trial Data Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Correlative Analytics and Integrated Clinical Trial Data's estimated annual revenue is currently $3.5M per year.(i)
  • Correlative Analytics and Integrated Clinical Trial Data's estimated revenue per employee is $184,211

Employee Data

  • Correlative Analytics and Integrated Clinical Trial Data has 19 Employees.(i)

Correlative Analytics and Integrated Clinical Trial Data's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Associate Director Clinical OperationsReveal Email/Phone
3
Director Technology SolutionsReveal Email/Phone
4
Director, Information & Data ManagementReveal Email/Phone
5
Director, Business DevelopmentReveal Email/Phone
6
Senior TMF ManagerReveal Email/Phone
7
Clinical Project ManagerReveal Email/Phone
8
Clinical Data ManagerReveal Email/Phone
9
Product ManagerReveal Email/Phone
10
Diector Clinical OperationsReveal Email/Phone

What Is Correlative Analytics and Integrated Clinical Trial Data?

keywords:N/A

N/A

Total Funding

19

Number of Employees

$3.5M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Correlative Analytics and Integrated Clinical Trial Data News

2022-04-20 - 3 Signals a Crypto Crash May Be Coming, According to Experts

Macro indicators, technical analysis and on-chain analytics can help traders ... The correlation of bitcoin and [ether] to the Nasdaq is...

2022-04-17 - Analysis: Positive real yields may spell more trouble for U.S. ...

RLV) - whose cash flows are more near-term - has had a negative 96% correlation with 10-year real rates, meaning they tend to move in...

2022-03-30 - How to Use Correlation to Make Predictions

The truth is, there are also times when a correlation is not only ... know — without further analysis — whether this relationship is causal.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M19-39%N/A
#2
$1.7M19-5%N/A
#3
$1.2M190%N/A
#4
N/A190%N/A
#5
$1.7M19N/AN/A